Allegion Is Maintained at Underweight by Barclays
Barclays Sticks to Their Sell Rating for Allegion (ALLE)
Allegion Is Maintained at Equal-Weight by Wells Fargo
Allegion Analyst Ratings
Wells Fargo Maintains Allegion(ALLE.US) With Hold Rating, Cuts Target Price to $140
Morgan Stanley Maintains Allegion(ALLE.US) With Hold Rating, Maintains Target Price $137
Wells Fargo Maintains Allegion(ALLE.US) With Hold Rating, Maintains Target Price $140
Morgan Stanley Maintains Allegion(ALLE.US) With Hold Rating, Raises Target Price to $137
Allegion Initiated With an Equal Weight at Morgan Stanley
Vertical Research Adjusts Price Target on Allegion Public to $138 From $150
Wells Fargo Maintains Allegion(ALLE.US) With Hold Rating, Maintains Target Price $152
Wells Fargo Sticks to Their Hold Rating for Allegion (ALLE)
Wells Fargo Reaffirms Their Hold Rating on Allegion (ALLE)
Wells Fargo Maintains Allegion(ALLE.US) With Hold Rating, Maintains Target Price $152
Redburn Atlantic Adjusts Price Target on Allegion Public to $165 From $152, Maintains Buy
Allegion Is Maintained at Underweight by Barclays
Barclays Maintains Allegion(ALLE.US) With Sell Rating, Raises Target Price to $137
Wells Fargo Maintains Allegion(ALLE.US) With Hold Rating, Maintains Target Price $152
Wells Fargo Remains a Hold on Allegion (ALLE)
Mizuho Securities Maintains Allegion(ALLE.US) With Hold Rating